Seminars in Diagnostic Pathology
Volume 23, Issue 3 , Pages 132-148 , August 2006

Acute and chronic hepatitis

  • Arief A. Suriawinata, MD

      Affiliations

    • Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    • ,
  • Swan N. Thung, MD

      Affiliations

    • Department of Pathology, The Lillian-Henry M. Stratton and Hans Popper, The Mount Sinai Medical Center, New York, New York.
    • Corresponding Author InformationAddress reprint requests and correspondence: Swan N. Thung, MD, The Mount Sinai Medical Center, Department of Pathology, Box 1194, One Gustave L. Levy Place, New York, NY 10029.

References 

  1. Siegel CA, Silas AM, Suriawinata AA, et al. Liver biopsy 2005: when and how?. Cleve Clin J Med. 2005;72:199–201
  2. Antonio LB, Suriawinata A, Thung SN. Liver tissue processing techniques. In:  Odze RD,  Goldblum JR,  Crawford JM editor. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Philadelphia, PA: Saunders; 2004;p. 739–756
  3. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol. 2000;32(suppl):39–47
  4. Leist M, Single B, Castoldi AF, et al. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 1997;185:1481–1486
  5. Theise ND. Liver stem cells: prospects for treatment of inherited and acquired liver diseases. Exp Open Biol Ther. 2003;3:403–408
  6. Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis (Prognostic value of bridging (subacute hepatic necrosis)). N Engl J Med. 1970;283:1063–1071
  7. Abe H, Beninger PR, Ikejiri N, et al. Light microscopic findings of liver biopsy specimens from patients with hepatitis type A and comparison with type B. Gastroenterology. 1982;82:938–947
  8. Kryger P, Christoffersen P. Liver histopathology of the hepatitis A virus infection: a comparison with hepatitis type B and non-A, non-B. J Clin Pathol. 1983;36:650–654
  9. Popper H, Thung SN, Gerber MA, et al. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology. 1983;3:906–912
  10. Gerber MA. Histopathology of HCV infection. Clin Liver Dis. 1997;1:529–541
  11. Allaire GS, Goodman ZD, Ishak KG, et al. Talc in liver tissue of intravenous drug abusers with chronic hepatitis (A comparative study). Am J Clin Pathol. 1989;92:583–588
  12. Horwitz CA, Henle W, Henle G, et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals (Report of 82 cases). Medicine. 1986;65:124–134
  13. Snover DC, Horwitz CA. Liver disease in cytomegalovirus mononucleosis: a light microscopical and immunoperoxidase study of six cases. Hepatology. 1984;4:408–412
  14. Kanj SS, Sharara AI, Clavien PA, et al. Cytomegalovirus infection following liver transplantation: review of the literature. Clin Infect Dis. 1996;22:537–549
  15. Becroft DM. Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis. Perspect Pediatr Pathol. 1981;6:203–241
  16. White NJ, Juel-Jensen BE. Infectious mononucleosis hepatitis. Semin Liver Dis. 1984;4:301–306
  17. Ishak KG. Granulomas of the liver. In:  Ioachim HL editors. Pathology of Granulomas. New York, NY: Raven Press; 1983;p. 307–369
  18. Kusne S, Schwartz M, Breinig MK, et al. Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis. 1991;163:1001–1007
  19. Krilov LR, Rubin LG, Frogel M, et al. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis. 1990;12:303–307
  20. Ishak KG, Walker DH, Coetzer JA. Viral hemorrhagic fevers with hepatic involvement: pathologic aspects with clinical correlations. Prog Liver Dis. 1982;7:495–515
  21. Phillips MJ, Blendis LM, Poucell S, et al. Syncytial giant-cell hepatitis (Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features). N Engl J Med. 1991;324:455–460
  22. Rosenberg HS, Oppenheimer EH, Esterly JR. Congenital rubella syndrome: The late effects and their relation to early lesions. Perspect Pediatr Pathol. 1981;6:183–202
  23. Bissell DM, Gores GJ, Laskin DL, et al. Drug-induced liver injury: mechanisms and test systems. Hepatology. 2001;33:1009–1013
  24. Benichou C. Criteria of drug-induced liver disorders (Report of an international consensus meeting). J Hepatol. 1990;11:272–276
  25. Takahashi Y, Okuda K. Fulminant and subfulminant hepatitis in Japan: etiological considerations. J Gastroenterol. 1993;12(suppl 3):19–21
  26. Johnson EI, Lanford RE, Solomon K. Chlorpromazine, eosinophilia, and hepatotoxicity. VA Med. 1979;106:683–684
  27. Liddle C, Goodwin B. Regulation of hepatic drug metabolism: role of the nuclear receptors PXR and CAR. Semin Liver Dis. 2002;22:115–122
  28. Gerber MA, Thung SN. Histology of the liver. Am J Surg Pathol. 1987;11:709–722
  29. Lebovics E, Thung SN, Schaffner F, et al. The liver in the acquired immunodeficiency syndrome: a clinical and histologic study. Hepatology. 1985;5:293–298
  30. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431–435
  31. Bedossa P, Poynard T The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24:289–293
  32. Scheuer P, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liv Dis. 2002;6:335–347
  33. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699
  34. Lok AS, McMahon BJ. Chronic hepatitis B: update of recommendations (AASLD practice guideline). Hepatology. 2004;39:1–5
  35. Kobayashi M, Tanaka E, Sodeyama T, et al. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology. 1996;23:695–699
  36. Adinolfi LE, Utili R, Andreana A, et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci. 2001;6:1677–1683
  37. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358–1364
  38. Guido M, Thung SN, Fattovich G, et al. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection. Mod Pathol. 1999;12:599–603
  39. De Torres M, Poynard T. Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann Hepatol. 2003;2:5–11
  40. Davies SE, Portmann BC, O’Grady JG, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology. 1991;13:150–157
  41. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatology. 1999;31:929–938
  42. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001;33:544–553
  43. Pessayre D, Larrey D. Acute and chronic drug-induced hepatitis. Baillieres Clin Gastroenterol. 1988;2:385–422
  44. Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. In:  MacSween RNM editors. Pathology of the Liver. New York, NY: Churchill Livingstone; 2002;p. 621–709
  45. Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liv Dis. 2002;6:399–420
  46. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liv Dis. 2005;9:37–53
  47. Jamal MM, Saadi Z, Morgan TR. Alcohol and hepatitis C. Dig Dis. 2005;23:285–296
  48. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:3–20
  49. Suriawinata A, Fiel MI. Liver pathology in obesity. Semin Liver Dis. 2004;24:363–370
  50. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol. 1998;15:246–258
  51. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641–649
  52. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–2474
  53. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321
  54. Llanos RM, Mercer JF. The molecular basis of copper homeostasis in copper-related disorders. DNA Cell Biol. 2002;21:259–270
  55. Sternlieb I, Scheinberg IH. Chronic hepatitis as a first manifestation of Wilson’s disease. Ann Intern Med. 1972;76:59–64
  56. Stromeyer FW, Ishak KG. Histology of the liver in Wilson’s disease: a study of 34 cases. Am J Clin Pathol. 1980;73:12–24
  57. Malone M, Mieli-Vergani G, Mowat AP, et al. The fetal liver in (PiZZ) α1-antitrysin deficiency: a report of five cases. Pediatr Pathol. 1989;9:623–631
  58. Talbot IC, Mowat AP. Liver disease in infancy: histological features and relationship to α1-antitrysin phenotype. J Clin Pathol. 1975;28:559–563

PII: S0740-2570(06)00170-5

doi: 10.1053/j.semdp.2006.11.001

Seminars in Diagnostic Pathology
Volume 23, Issue 3 , Pages 132-148 , August 2006

Article Tools

* Image Usage & Resolution